Voyager Therapeutics, Inc.
VYGR· Nasdaq
Quarterly figures for Voyager Therapeutics, Inc., with source filings when available.
50 quarters. Mar 31, 2014 to Jun 30, 2026. USD.
Voyager Therapeutics, Inc. has filed its 10-Q within 36 to 43 days of period end across its last 8 quarters. The 10-K runs 56 to 70 days.
Voyager Therapeutics, Inc. · CIK 1640266 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | Aug 6, 2026 · after-hours | Aug 6, 2026 | 37 d | 10-Q | $3.17M | −39.1% | -$0.40 | |
| Q1 2026 |
|---|
| Mar 31, 2026 |
| May 7, 2026 · after-hours |
| May 7, 2026 |
| 37 d |
| 10-Q |
| $2.59M |
| −59.9% |
| -$0.47 |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Mar 9, 2026 · after-hours | Mar 9, 2026 | 68 d | 10-K | $15.34M | +144.3% | — | |
| Q3 2025 | Sep 30, 2025 | Nov 10, 2025 · pre-market | Nov 10, 2025 | 41 d | 10-Q | $13.37M | −45.7% | -$0.47 | |
| Q2 2025 | Jun 30, 2025 | Aug 6, 2025 · after-hours | Aug 6, 2025 | 37 d | 10-Q | $5.20M | −82.4% | -$0.57 | |
| Q1 2025 | Mar 31, 2025 | May 6, 2025 · after-hours | May 6, 2025 | 36 d | 10-Q | $6.47M | −66.8% | -$0.53 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | Mar 11, 2025 · after-hours | Mar 11, 2025 | 70 d | 10-K | $6.28M | −93.0% | — | |
| Q3 2024 | Sep 30, 2024 | Nov 12, 2024 · after-hours | Nov 12, 2024 | 43 d | 10-Q | $24.63M | +433.8% | -$0.16 | |
| Q2 2024 | Jun 30, 2024 | Aug 6, 2024 · after-hours | Aug 6, 2024 | 37 d | 10-Q | $29.58M | +509.5% | -$0.18 | |
| Q1 2024 | Mar 31, 2024 | May 13, 2024 · after-hours | May 13, 2024 | 43 d | 10-Q | $19.52M | −87.0% | -$0.20 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | Feb 28, 2024 · after-hours | Feb 28, 2024 | 59 d | 10-K | $90.06M | — | — | |
| Q3 2023 | Sep 30, 2023 | Nov 6, 2023 · after-hours | Nov 6, 2023 | 37 d | 10-Q | $4.61M | −88.8% | -$0.59 | |
| Q2 2023 | Jun 30, 2023 | Aug 3, 2023 · pre-market | Aug 3, 2023 | 34 d | 10-Q | $4.85M | +581.6% | -$0.51 | |
| Q1 2023 | Mar 31, 2023 | May 9, 2023 · pre-market | May 9, 2023 | 39 d | 10-Q | $150.48M | +22,769.3% | $2.94 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | Mar 7, 2023 · pre-market | Mar 7, 2023 | 66 d | 10-K | — | — | — | |
| Q3 2022 | Sep 30, 2022 | Nov 8, 2022 · pre-market | Nov 8, 2022 | 39 d | 10-Q | $41.09M | +2,672.3% | $0.45 | |
| Q2 2022 | Jun 30, 2022 | Aug 4, 2022 · after-hours | Aug 4, 2022 | 35 d | 10-Q | $712.00K | −47.5% | -$0.50 | |
| Q1 2022 | Mar 31, 2022 | May 4, 2022 · after-hours | May 4, 2022 | 34 d | 10-Q | $658.00K | −89.9% | -$0.56 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Dec 31, 2021 | Mar 8, 2022 · pre-market | Mar 8, 2022 | 67 d | 10-K | $28.08M | +329.5% | — | |
| Q3 2021 | Sep 30, 2021 | — | Nov 2, 2021 | 33 d | 10-Q | $1.48M | −98.7% | -$0.67 | |
| Q2 2021 | Jun 30, 2021 | — | Aug 9, 2021 | 40 d | 10-Q | $1.36M | −95.3% | -$0.80 | |
| Q1 2021 | Mar 31, 2021 | — | May 10, 2021 | 40 d | 10-Q | $6.50M | −64.0% | -$0.58 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020derived | Dec 31, 2020 | — | Feb 25, 2021 | 56 d | 10-K | $6.54M | −80.0% | — | |
| Q3 2020 | Sep 30, 2020 | — | Nov 9, 2020 | 40 d | 10-Q | $117.84M | +476.7% | $2.27 | |
| Q2 2020 | Jun 30, 2020 | — | Aug 10, 2020 | 41 d | 10-Q | $28.68M | −37.8% | -$0.23 | |
| Q1 2020 | Mar 31, 2020 | — | May 6, 2020 | 36 d | 10-Q | $18.07M | +247.6% | -$0.66 | |
| FY 2019 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2019 | Dec 31, 2019 | — | Mar 3, 2020 | 63 d | 10-K | $32.67M | +1,527.2% | -$0.34 | |
| Q3 2019 | Sep 30, 2019 | — | Nov 6, 2019 | 37 d | 10-Q | $20.43M | +875.8% | -$0.41 | |
| Q2 2019 | Jun 30, 2019 | — | Aug 9, 2019 | 40 d | 10-Q | $46.09M | +1,689.8% | $0.29 | |
| Q1 2019 | Mar 31, 2019 | — | May 7, 2019 | 37 d | 10-Q | $5.20M | +451.7% | -$0.81 | |
| FY 2018 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2018 | Dec 31, 2018 | — | Feb 26, 2019 | 57 d | 10-K | $2.01M | −68.4% | -$0.70 | |
| Q3 2018 | Sep 30, 2018 | — | Nov 7, 2018 | 38 d | 10-Q | $2.09M | +82.4% | -$0.63 | |
| Q2 2018 | Jun 30, 2018 | — | Aug 7, 2018 | 38 d | 10-Q | $2.58M | +118.8% | -$0.80 | |
| Q1 2018 | Mar 31, 2018 | — | May 10, 2018 | 40 d | 10-Q | $942.00K | −35.7% | -$0.63 | |
| FY 2017 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2017 | Dec 31, 2017 | — | Mar 14, 2018 | 73 d | 10-K | $6.35M | +168.7% | -$0.40 | |
| Q3 2017 | Sep 30, 2017 | — | Nov 2, 2017 | 33 d | 10-Q | $1.15M | −65.3% | -$0.89 | |
| Q2 2017 | Jun 30, 2017 | — | Aug 8, 2017 | 39 d | 10-Q | $1.18M | −68.4% | -$0.73 | |
| Q1 2017 | Mar 31, 2017 | — | May 9, 2017 | 39 d | 10-Q | $1.46M | −69.7% | -$0.65 | |
| FY 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2016 | Dec 31, 2016 | — | Mar 15, 2017 | 74 d | 10-K | $2.36M | −52.2% | $0.57 | |
| Q3 2016 | Sep 30, 2016 | — | Nov 10, 2016 | 41 d | 10-Q | $3.31M | −33.0% | $0.35 | |
| Q2 2016 | Jun 30, 2016 | — | Aug 11, 2016 | 42 d | 10-Q | $3.72M | −23.8% | $0.37 | |
| Q1 2016 | Mar 31, 2016 | — | May 12, 2016 | 42 d | 10-Q | $4.83M | +87.5% | $0.29 | |
| FY 2015 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2015 | Dec 31, 2015 | — | Mar 17, 2016 | 77 d | 10-K | $4.94M | — | $0.67 | |
| Q3 2015 | Sep 30, 2015 | — | Dec 17, 2015 | 78 d | 10-Q | $4.94M | — | $5.25 | |
| Q2 2015 | Jun 30, 2015 | — | — | — | — | $4.88M | — | $5.80 | |
| Q1 2015 | Mar 31, 2015 | — | — | — | — | $2.58M | — | $15.81 | |
| FY 2014 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2014 | Dec 31, 2014 | — | — | — | — | — | — | $6.58 | |
| Q3 2014 | Sep 30, 2014 | — | — | — | — | — | — | $6.45 | |
| Q2 2014 | Jun 30, 2014 | — | — | — | — | — | — | $8.11 | |
| Q1 2014 | Mar 31, 2014 | — | — | — | — | — | — | $6.93 | |